| Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant X Deng, MA Garcia-Knight, MM Khalid, V Servellita, C Wang, MK Morris, ... Cell 184 (13), 3426-3437. e8, 2021 | 438 | 2021 |
| Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation X Deng, MA Garcia-Knight, MM Khalid, V Servellita, C Wang, MK Morris, ... MedRxiv, 2021 | 269 | 2021 |
| Species-and site-specific genome editing in complex bacterial communities BE Rubin, S Diamond, BF Cress, A Crits-Christoph, YC Lou, AL Borges, ... Nature microbiology 7 (1), 34-47, 2022 | 154 | 2022 |
| Synthetic evolutionary origin of a proofreading reverse transcriptase JW Ellefson, J Gollihar, R Shroff, H Shivram, VR Iyer, AD Ellington Science 352 (6293), 1590-1593, 2016 | 136 | 2016 |
| Controlling and enhancing CRISPR systems H Shivram, BF Cress, GJ Knott, JA Doudna Nature chemical biology 17 (1), 10-19, 2021 | 133 | 2021 |
| Potent CRISPR-Cas9 inhibitors from Staphylococcus genomes KE Watters, H Shivram, C Fellmann, RJ Lew, B McMahon, JA Doudna Proceedings of the National Academy of Sciences 117 (12), 6531-6539, 2020 | 55 | 2020 |
| Bivalent chromatin domains in glioblastoma reveal a subtype-specific signature of glioma stem cells AW Hall, AM Battenhouse, H Shivram, AR Morris, MC Cowperthwaite, ... Cancer research 78 (10), 2463-2474, 2018 | 42 | 2018 |
| Chd1 co-localizes with early transcription elongation factors independently of H3K36 methylation and releases stalled RNA polymerase II at introns D Park, H Shivram, VR Iyer Epigenetics & chromatin 7, 1-11, 2014 | 29 | 2014 |
| Identification and removal of sequencing artifacts produced by mispriming during reverse transcription in multiple RNA-seq technologies H Shivram, VR Iyer Rna 24 (9), 1266-1274, 2018 | 20 | 2018 |
| ELF4 Is a Target of miR-124 and Promotes Neuroblastoma Proliferation and Undifferentiated State A Kosti, L Du, H Shivram, M Qiao, S Burns, JG Garcia, A Pertsemlidis, ... Molecular Cancer Research 18 (1), 68-78, 2020 | 17 | 2020 |
| MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network H Shivram, SV Le, VR Iyer Genome Research 29 (2), 184-192, 2019 | 17 | 2019 |
| Targeting novel sites: The amino-terminal DNA binding domain of non-LTR retrotransposons is an adaptable module that is implicated in changing site specificities. H Shivram, D Cawley, SM Christensen Mobile Genetic Elements 1 (3), 169-178, 2011 | 12 | 2011 |
| Diverse ATPase proteins in mobilomes constitute a large potential sink for prokaryotic host ATP H Shim, H Shivram, S Lei, JA Doudna, JF Banfield Frontiers in Microbiology 12, 691847, 2021 | 10 | 2021 |
| A protein antagonist of activation-induced cytidine deaminase encoded by a complex mouse retrovirus GB Singh, H Byun, AF Ali, F Medina, D Wylie, H Shivram, AK Nash, ... MBio 10 (4), 10.1128/mbio. 01678-19, 2019 | 7 | 2019 |
| PRC2 activates interferon-stimulated genes indirectly by repressing miRNAs in glioblastoma H Shivram, SV Le, VR Iyer Plos one 14 (9), e0222435, 2019 | 6 | 2019 |
| Tocilizumab treatment leads to early resolution of lymphopenia and myeloid dysregulation in patients hospitalized with COVID-19 H Shivram, JA Hackney, CM Rosenberger, A Teterina, A Qamra, ... bioRxiv, 2022.10. 27.514096, 2022 | 3 | 2022 |
| IgG immune complexes inhibit naïve T cell proliferation and suppress effector function in cytotoxic T cells W Charab, MG Rosenberger, H Shivram, JM Mirazee, M Donkor, ... Frontiers in Immunology 12, 713704, 2021 | 3 | 2021 |
| Prognostic value of severe acute respiratory syndrome coronavirus‐2 viral load and antibodies in patients hospitalized with COVID‐19 RN Bauer, A Teterina, H Shivram, J McBride, CM Rosenberger, F Cai, ... Clinical and Translational Science 16 (6), 1049-1062, 2023 | 2 | 2023 |
| A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling JA Hackney, H Shivram, J Vander Heiden, C Overall, L Orozco, X Gao, ... Iscience 26 (10), 2023 | 1 | 2023 |
| Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19 H Shivram, JA Hackney, CM Rosenberger, A Teterina, A Qamra, ... Iscience 26 (9), 107597, 2023 | 1 | 2023 |
Vishy IyerUniversity of Texas at AustinVerified email at utexas.edu
